February 3, 2020
ARLINGTON, Va. — HDA Executive Vice President of Government Affairs Patrick Kelly released the following statement in response to a new Government Accountability Office (GAO) report, Drug Control: Actions Needed to Ensure Usefulness of Data on Suspicious Opioid Orders.
“HDA was pleased to provide feedback to GAO as they developed their recent report. Distributors actively supported the inclusion of two recently established programs — the ARCOS (Automation of Reports and Consolidated Orders System) Enhanced Lookup Buyer Statistic Tool and the Suspicious Order Reporting System Online database — as part of the SUPPORT for Patients and Communities Act.
“Both programs foster much-needed communication and information sharing as well as welcomed capabilities for both healthcare stakeholders and the DEA. However, as identified in the GAO report, work remains to ensure the programs are implemented without any operational challenges.
“HDA will continue to provide the DEA with feedback and suggestions to implement necessary changes to the ARCOS tool, specifically the single query and bulk data limitations as well as providing additional login credentials for registrants.
“We commend the DEA Office of Diversion Control for collaborating with our industry and maintaining an open line of communication during this process. We look forward to ongoing discussions with our supply chain partners and government stakeholders as we continue to advance a comprehensive approach to reversing our country’s prescription opioid abuse epidemic.”
Learn more about pharmaceutical distributors’ efforts to combat prescription drug abuse here.
The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s non-profit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.